Manipal Health Enterprises GMP ₹33 ▲ 5.59%Xtranet Technologies GMP ₹9 ▲ 7.09%Indo-MIM GMP ₹171 ▲ 35.26%Poojaa Precision Engg. GMP ₹195 ▲ 64.78%Lohia Corp GMP ₹11 ▲ 2.59%Advance Technoforge GMP ₹5.5 ▲ 5.79%Metalic Technoforge GMP ₹6 ▲ 7.79%Gulf Lloyds GMP ₹1 ▲ 1.00%
IPO Index
S
Sanjay Bambhaniya · May 20, 2026

Bio Medica Laboratories SME IPO Details 2026

SME Book Build Listed
Pharmaceutical
NSE SME
Price Band
₹132 - ₹139
Issue Size
₹52.43 Cr.
Lot Size
1000 Share
Min. Investment
₹1,39,000
Live GMP ₹0
0.00% Est. Listing: ₹139
SIP CalcCompare
IPO Timeline
DRHP FILED May 21, 2026
OPEN May 21, 2026
CLOSE May 25, 2026
ALLOTMENT May 26, 2026
LISTING May 29, 2026
IPO DETAILS REVIEW GMP SUBSCRIPTION ALLOTMENT STATUS

Bio Medica Laboratories

Company overview & key insights

The Bio Medica Laboratories size is ₹52.43 crore, including a fresh issue of ₹47.19 crore and an offer for sale of ₹5.24 crore. It is a book build issue. The IPO issue opens on May 21, 2026 and closes on May 25, 2026. The share allotment is expected on May 26, 2026, and the listing date is May 29, 2026. Bio Medica Laboratories is based in Indore and operates in the Pharmaceutical sector. It filed its DRHP on 8th August 2025 and will list its shares on NSE SME. Skyline Financial Services Pvt.Ltd. is the registrar, while Narnolia Financial Services Ltd. serves as the merchant banker for the offer.

Bio-Medica-SME

IPO Highlights

Key details & important dates

IPO Details

Total Issues ₹52.43 Cr.
Fresh Issue 33,95,000 shares (agg. up to ₹47.19 Cr)
Offer for Sale 3,77,000 shares (agg. up to ₹5.24 Cr)
IPO Price Band ₹132 - ₹139
Face Value ₹10 per share
Lot Size 1000 Share
Listed On NSE SME

IPO Dates

DRHP Filed May 21, 2026
Issue Open May 21, 2026
Issue Close May 25, 2026
Allotment Date May 26, 2026
Refunds Initiation May 27, 2026
Credit of Shares May 27, 2026
Listing Date May 29, 2026

Stay up-to-date with all IPO details. Do not miss any deadlines & avoid missed investment opportunities.

How to Apply

IPO Issue Structure

Reservation & Lot Size Details

The company has reserved shares for various investor categories. The Retail Shares reservation is 50.01% (17,92,000 shares), and QIB has 1.00% (36,000). Further, the minimum lot size is 1,000 shares. The anchor investor reservation is —% (— shares), and the market maker reservation is 5.01% (1,89,000 shares).

IPO Reservation

QIB 36,000
Anchor Investor –
QIB (Ex. Anchor) 36,000
NII (HNI) 17,55,000 (48.98%)
bNII > ₹10L 11,70,000 (31.02%)
sNII < ₹10L 5,85,000 (15.51%)
Retail 17,92,000 (50.01%)
Employee 1,89,000 (approx. ₹3.00 crore)
Shareholder 37,72,000 (100.00%)

IPO Lot Size

Retail (Min)
2 Lot | 2000 Shares
₹2,78,000
Small Investor Quota
Retail (Max)
2 Lot | 2000 Shares
₹2,78,000
Retail Investment Limit
S-HNI (Min)
3 Lot | 3000 Shares
₹4,17,000
Small HNI (₹2L – ₹10L)
S-HNI (Max)
7 Lot | 7000 Shares
₹9,73,000
Small HNI (Up to ₹10 L)
B-HNI (Min)
8 Lot | 8000 Shares
₹11,12,000
Big HNI (Above ₹10L)
Zerodha Apply Now Upstox Apply Now Angel One Apply Now

Tip: Determine your investment budget and your exact allotment chances based on your investor category.

Investment Guide

IPO Documents & GMP

Prospectus & Grey Market Premium

On 8th August 2025 the company filed its Draft Red Herring Prospectus. The Red Herring Prospectus is available to understand the business operations, financials, and the risks involved.

DRHP Document Draft Red Herring Prospectus
RHP Document Red Herring Prospectus

IPO GMP

Live

The Grey Market Premium indicates the extra price that people pay in the unofficial market. This value changes daily based on demand for the shares.

Track live GMP Today

Financial Performance (₹ in Cr)

Period Ended30 Nov 202531 Mar 202531 Mar 202431 Mar 2023
Total Income28.6338.3315.3416.25
Profit After Tax8.669.792.50.33
EBITDA13.4515.215.631.7
Net Worth17.1214.734.942.44
Assets65.1739.1219.5317.57
Total Debt38.1715.0110.499.61

Key Performance Indicator

ParticularsNov 30, 2025FY25FY24FY23
EBITDA Margin (%)47.1140.1437.5310.54
PAT Margin (%)30.3525.6316.342.03
EPS (₹)—10.672.720.36
ROE (%)54.41132.4831.016.68
ROCE (%)23.2248.229.9210.16
ROA (%)—25.0312.751.88
Debt to Equity (x)2.232.031.241.94

IPO Financial Snapshot

Objectives & Key Metrics

IPO Objectives

Repayment of loan ₹6.50 Cr.
Enhancement of its existing production capabilities by setting up of new manufacturing facility at the existing premises ₹28.50 Cr.
General Corporate Purposes ₹0.00 Cr.
Total Fund Requirement ₹35.00 Cr.

IPO Key Metrics

Pre IPO EPS
10.67
Earnings Per Share
Post IPO EPS
10.33
Earnings Per Share
Pre IPO P/E
13.03
Price to Earnings
Post IPO P/E
13.45
Price to Earnings
Market Capitalization ₹174.79 Cr.
Insight: IPO objectives and KPIs provide measurable data to track the company’s real growth.
IPO KPIs

Listing Day Trading
NSE SME

Final Issue Price ₹139
Open ₹111.20
Low ₹105.65
High ₹116.75
Last Trade
₹115.80
▼ – 16.69%
Check IPO Performance

Quick Links

IPO GMP
Live
Live SubscriptionCompare BrokersAll Brokers
Pro
IPO CalendarTop PerformersUpcoming IPOsIPO NewsList of All Articles…

Calculators

IPO Return
Popular
Mutual FundSIPLumpsumCAGRCompare IPOs
New
SWPListing GrainView All Calculators →

Bio Medica Laboratories Ltd. Company Details

Company Profile · Overview

Bio Medica Laboratories Ltd. started its business in 2015. The company operates in the Pharmaceutical sector. It manufactures pharmaceutical parenteral formulations for the human and veterinary market. Its main office is in Indore. The company holds several quality certificates for its operations like GMP and GLP certificates from Food and Drugs Administration of Madhya Pradesh. The firm owns two factories in Indore. It runs a business to business contract manufacturing model. The team creates solutions for clients based on specific requirements.

Main Offerings

Liquid Injectables with fifty eight products
Dry powder injectables with fifteen products
Generic and branded medications
Over the counter pharma products

Key Strengths

Very wide product portfolio
Highly experienced promoter group
Excellent quality assurance setups
Strong ties with clients
Company Address: Plot No. 11B-11C, Sector-E, Sanwer Road Industrial Area, Industrial Estate, Indore, Madhya Pradesh, 452015. +91 7314102751 | companysecretary@biomedica.co.in
Intermediaries
Registrar
Skyline Financial Services Pvt.Ltd.
02228511022
ipo@skylinerta.com
Lead Manager
Narnolia Financial Services Ltd.
Market Maker
Prabhat Financial Services Ltd.
RESERVATION 1,89,000 shares (agg. up to ₹3 Cr)
Promoters
Promoter Group
Mr. Mukesh Mehta Mr. Pradeep Mehta

Frequently Asked Questions

5 FAQs
What is the Bio Medica Laboratories IPO?

The Bio Medica Laboratories IPO is a total issue of ₹52.43 crore in the Pharmaceutical sector. This includes a fresh issue of ₹47.19 crore. It also contains an offer for sale of ₹5.24 crore. The public offer opens on May 21, 2026. The subscription period ends on May 25, 2026.

What is the lot size for a retail investor?

The minimum application size is 2 lots. This minimum lot size contains 2,000 shares. An investor needs ₹2,78,000 for this application.

Where will the shares list?

The shares will list on the NSE SME platform. The platform handles small and medium enterprise listings.

Who are the promoters of this company?

Mr. Mukesh Mehta is the main promoter. Mr. Pradeep Mehta also promotes the business.

What is the main objective of this issue?

The firm wants to set up a new manufacturing facility. It will also clear its existing debt.

Sanjay Bambhaniya
Sanjay Bambhaniya
Sanjay has 8+ years of experience in data-driven IPO insights. His expertise in digital marketing and web development complements his financial knowledge and helps him to develop effective fintech solutions. He is an entrepreneur and director who helps investors understand complex primary market trends in easy-to-understand IPO reports, news, and updates.
Discussion & Feedback
0 Comments

No comments yet. Be the first to share your thoughts!

Editorial Pickup

In the Spotlight

Important business websites and news channels talk about the IPO INDEX.

Media Feature

Logo